We are live on
!
Find out more
Russell Investments Group Portfolio holdings
AUM
$114B
1-Year Est. Return
41.71%
This Fund
S&P 500
This Quarter
Est. Return
+10.82%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$48.6B
AUM Growth
+$3.08B
(+6.8%)
Cap. Flow
+$3.24M
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
3,030
New
136
Increased
1,065
Reduced
1,247
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$806M |
| 2 |
Prologis
PLD
|
+$81.5M |
| 3 |
SABRP
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
|
+$72.2M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$71M |
| 5 |
SLB Ltd
SLB
|
+$65.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$109M |
| 2 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$80.1M |
| 3 |
Applied Materials
AMAT
|
+$46.5M |
| 4 |
Booking.com
BKNG
|
+$43.8M |
| 5 |
Amazon
AMZN
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 13.97% |
| 4 | Real Estate | 9.14% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CVS Health
CVS
$122B
| $151M | 0.31% |
1,624,227
+7,502
| +0.5% | +$724K |
|
52
CME Group
CME
$94.8B
| $149M | 0.31% |
886,585
+167,135
| +23% | +$29M |
|
53
Thermo Fisher Scientific
TMO
$220B
| $148M | 0.31% |
269,059
+7,668
| +3% | +$4.06M |
|
54
Pfizer
PFE
$153B
| $148M | 0.31% |
2,891,836
-44,539
| -2% | -$2.14M |
|
55
Coca-Cola
KO
$375B
| $148M | 0.31% |
2,325,836
-86,650
| -4% | -$5.23M |
|
56
Medtronic
MDT
$112B
| $148M | 0.3% |
1,902,965
+106,462
| +6% | +$8.63M |
|
57
Mid-America Apartment Communities
MAA
$15.7B
| $145M | 0.3% |
923,739
+203,328
| +28% | +$31.7M |
|
58
Micron Technology
MU
$991B
| $145M | 0.3% |
2,902,121
-491,948
| -14% | -$26.9M |
|
59
McKesson
MCK
$101B
| $144M | 0.3% |
384,278
-18,141
| -5% | -$6.77M |
|
60
Bristol-Myers Squibb
BMY
$132B
| $144M | 0.3% |
1,998,126
+93,591
| +5% | +$7.06M |
|
61
Welltower
WELL
$171B
| $142M | 0.29% |
2,162,270
+420,409
| +24% | +$27M |
|
62
ConocoPhillips
COP
$141B
| $141M | 0.29% |
1,192,781
+100,396
| +9% | +$12.2M |
|
|
63
Bank of America
BAC
$442B
| $141M | 0.29% |
4,246,808
-767,008
| -15% | -$26.4M |
|
64
Zoetis
ZTS
$30B
| $139M | 0.29% |
946,204
+158,830
| +20% | +$23.5M |
|
65
T-Mobile US
TMUS
$190B
| $137M | 0.28% |
981,658
-2,620
| -0.3% | -$376K |
|
66
Moody's
MCO
$82.7B
| $137M | 0.28% |
489,784
-20,810
| -4% | -$5.69M |
|
67
AbbVie
ABBV
$435B
| $137M | 0.28% |
845,316
-73,809
| -8% | -$11.3M |
|
68
Verizon
VZ
$196B
| $131M | 0.27% |
3,331,164
-31,642
| -0.9% | -$1.19M |
|
69
TJX Companies
TJX
$178B
| $128M | 0.26% |
1,608,726
+24,313
| +2% | +$1.8M |
|
70
Gilead Sciences
GILD
$165B
| $128M | 0.26% |
1,490,285
-287,801
| -16% | -$22.8M |
|
71
NVIDIA
NVDA
$5.42T
| $127M | 0.26% |
8,713,660
-1,045,620
| -11% | -$15.3M |
|
72
Comcast
CMCSA
$90B
| $126M | 0.26% |
3,608,834
-2,351
| -0.1% | -$77.8K |
|
73
Cheniere Energy
LNG
$52.9B
| $126M | 0.26% |
839,711
-95,688
| -10% | -$16M |
|
74
Walmart Inc
WMT
$890B
| $126M | 0.26% |
2,656,203
+427,086
| +19% | +$20.3M |
|
75
Abbott
ABT
$187B
| $123M | 0.25% |
1,116,356
-32,286
| -3% | -$3.34M |
|
Similar funds
VAM
Russell Investments Group's Q4 2022 Portfolio in Review
As of Q4 2022, Russell Investments Group held 3,030 positions worth $48.6B, up 6.8% from $45.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Russell Investments Group's Q4 2022 filing shows 136 new, 1,065 increased, 1,247 reduced and 140 closed positions. Its largest new stake was Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock: 940,000 shares worth $791K. The largest sale was Duke Realty Corp., an estimated $109M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Russell Investments Group's largest Q4 2022 buy was Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock: 940,000 shares worth $791K.
- Russell Investments Group added most to Bank of America Series L in Q4 2022, an estimated $806M increase.
- Russell Investments Group's biggest Q4 2022 reduction was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $80.1M.
- Russell Investments Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $109M.
- Russell Investments Group's ten largest holdings make up 14% of its $48.6B portfolio in Q4 2022.
- Russell Investments Group opened 136 new positions and closed 140 in Q4 2022.
- Russell Investments Group's portfolio value rose 6.8% quarter-over-quarter to $48.6B.
Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.